Patent US5893100A successfully refreshed from Google Patents.
Patent US4761867A successfully refreshed from Google Patents.
Patent US4861707A successfully refreshed from Google Patents.
US4861707A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Human immunodeficiency virus antigen
Assignee: EIDP Inc
•
Filing: 1987-02-02
•
Granted: 1989-08-29
•
Expires: 2007-02-02
Abstract
Abstract A recombinant peptide displaying the antigenicity of Human Immunodeficiency Virus (HIV) viral antigens is disclosed. The peptide comprises an antigenic segment having about 150 to about 400 amino acids corresponding to at least about 30 amino acids of the C-terminal of the gp120 domain and at least about 120 amino acids of the N-terminal of the gp41 domain.
Inventors
- 👤 Lucinda A. Ivanoff
- 👤 Steven R. Petteway
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-09 01:05
CPC Classifications
C; C07; C07K; C07K14/00; C07K14/005; A; A61; A61K; A61K39/00; C07K2319/00; C07K2319/40; C12; C12N; C12N2740/00; C12N2740/00011; C12N2740/10011; C12N2740/16011; C12N2740/16111; C12N2740/16122; Y; Y02; Y02A; Y02A50/00; Y02A50/30; Y10; Y10S; Y10S435/00; Y10S435/974; Y10S436/00; Y10S436/807; Y10S436/808; Y10S436/811; Y10S530/00; Y10S530/82; Y10S530/825; Y10S530/826; Y10S930/00; Y10S930/01; Y10S930/22; Y10S930/221
Claims Analysis
Total Claims: 10
Claim 1
Independent Claim
62 words
A recumbinant peptide displaying the antigenicity of Human Immunodeficiency Virus (HIV) viral antigens comprising an antigenic segment having about 286 amino acids corresponding to about 46 amino acids of the C-terminal region of the gp120 domain and about 240 amino acids of the N-terminal region of the gp41 domain, said antigenic segment corresponding to the amino acid sequence shown in FIG. 2.
Claim 2
Dependent Claim
62 words
A recumbinant peptide displaying the antigenicity of Human Immunodeficiency Virus (HIV) viral antigens comprising an antigenic segment having about 286 amino acids corresponding to about 46 amino acids of the C-terminal region of the gp120 domain and about 240 amino acids of the N-terminal region of the gp41 domain, said antigenic segment corresponding to the amino acid sequence shown in FIG. 2.
Claim 3
Dependent Claim
33 words
A peptide as defined in claim 1, wherein the antigenic segment has an amino acid sequence which corresponds to that encoded by the BgIII to BamH1 nucleatide sequence of HIv shown in FIG.2.
Claim 4
Dependent Claim
62 words
A peptide as defined in claim 1, wherein the peptide contains about 340 amino acids which correspond to about 54 amino acids from the N-terminal region of the poliovirus sequence of pEXC, about 46 amino acids of the C-terminal region of the gp120 domain and about 240 amino acids of the N-terminal region of the gp41 domain, as shown in FIG. 4.
Claim 5
Dependent Claim
57 words
In a diagnostic kit comprising a collection of materials containing all major components used for detecting antibodies to HIV in a biological sample and comprising a container containing an HIV antigen, and means for detecting an immune reaction of HIV antibodies with said HIV antigen, the improvement wherein the HIV antigen comprises a peptide of claim I.
Claim 6
Dependent Claim
57 words
In a diagnostic kit comprising a collection of materials containing all major components used for detecting antibodies to HIV in a biological sample and comprising a container containing an HIV antigen, and means for detecting an immune reaction of HIV antibodies with said HIV antigen, the improvement wherein the HIV antigen comprises a peptide of claim 2.
Claim 7
Dependent Claim
57 words
In a diagnostic kit comprising a collection of materials containing all major components used for detecting antibodies to HIV in a biological sample and comprising a container containing an HIV antigen, and means for detecting an immune reaction of HIV antibodies with said HIV antigen, the improvement wherein the HIV antigen comprises a peptide of claim 3.
Claim 8
Dependent Claim
39 words
In a method for detecting antibodies to HIV in a biological sample wherein the biological sample is contacted with an HIV antigen and immunoreactivity is detected, the improvement comprising contacting the biological sample with a peptide of claim 1.
Claim 9
Dependent Claim
40 words
In a method for detecting an antibodies to HIV in a biological sample wherein the biological sample is contacted with an HIV antigen and immunoreactivity is detected, the improvement comprising contacting the biological sample with a peptide of claim 2.
Claim 10
Dependent Claim
37 words
In a process for detecting antibodies to HIV in a biological sample comprising contacting said sample with a peptide which is immunoreactive with said antibodies and detecting immunoreactivity, the improvement comprising employing the peptide of claim 3.
References Cited (Backward Citations)
US4708818A
Cited
US4716102A
Cited
WO1986001535A1
Cited
EP0185444A2
Cited
US4692403A
Cited
EP0199301A1
Cited
US4629783A
Cited
US4661445A
Cited
EP0227169A2
Cited
US4753873A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1992-08-28 | 1993-02-27 | 1993-08-29 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1996-08-28 | 1997-02-27 | 1997-08-29 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2000-08-28 | 2001-02-27 | 2001-08-29 | $7700.00 | Window Closed / Lapsed |